Amgen Inc. Goodwill, Foreign Currency Translation Gain (Loss)
Amgen Inc. (AMGN) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$12.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05
- Amgen Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$6.00M, a 120.69% decline year-over-year.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$6.00M, a 175.00% decline year-over-year.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $4.00M.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was $2.00M, a 87.50% decline year-over-year.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $43.00M.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$17.00M, a 254.55% decline from fiscal 2023.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $11.00M.
- Amgen Inc. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$12.00M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$12.00M 10-Q · filed 2026-08-05 | -$8.00M derived: sum of 3 quarters · filed 2026-08-05 | -$6.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$6.00M 10-Q · filed 2026-05-01 | -$2.00M derived: sum of 2 quarters · filed 2026-05-01 | $0.00 derived: sum of 3 quarters · filed 2026-05-01 | $29.00M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2025-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.00M derived: sum of 2 quarters · filed 2026-02-13 | $35.00M derived: sum of 3 quarters · filed 2026-02-13 | $43.00M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $31.00M derived: sum of 2 quarters · filed 2025-11-05 | $39.00M 10-Q · filed 2025-11-05 | $18.00M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2025-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $37.00M 10-Q · filed 2025-08-06 | $16.00M derived: sum of 3 quarters · filed 2026-02-13 | $32.00M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2025-03-31 | $8.00M 10-Q · filed 2025-05-02 | -$13.00M derived: sum of 2 quarters · filed 2026-02-13 | $3.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.00M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-12-31 | -$21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$5.00M derived: sum of 2 quarters · filed 2026-02-13 | -$7.00M derived: sum of 3 quarters · filed 2026-02-13 | -$17.00M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $14.00M derived: sum of 2 quarters · filed 2024-10-31 | $4.00M 10-Q · filed 2024-10-31 | $13.00M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2024-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$12.00M 10-Q · filed 2024-08-07 | -$3.00M derived: sum of 3 quarters · filed 2025-02-14 | -$11.00M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2024-03-31 | -$10.00M 10-Q · filed 2024-05-03 | -$1.00M derived: sum of 2 quarters · filed 2025-02-14 | -$9.00M derived: sum of 3 quarters · filed 2025-02-14 | -$5.00M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.00M derived: sum of 2 quarters · filed 2025-02-14 | $5.00M derived: sum of 3 quarters · filed 2025-02-14 | $11.00M 10-K · filed 2025-02-14 | |
| 2023-09-30 | -$8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$4.00M derived: sum of 2 quarters · filed 2023-10-31 | $2.00M 10-Q · filed 2023-10-31 | $41.00M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2023-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $10.00M 10-Q · filed 2023-08-04 | $49.00M derived: sum of 3 quarters · filed 2024-02-14 | $30.00M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2023-03-31 | $6.00M 10-Q · filed 2023-04-28 | $45.00M derived: sum of 2 quarters · filed 2024-02-14 | $26.00M derived: sum of 3 quarters · filed 2024-02-14 | $9.00M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $20.00M derived: sum of 2 quarters · filed 2024-02-14 | $3.00M derived: sum of 3 quarters · filed 2024-02-14 | -$12.00M 10-K · filed 2024-02-14 | |
| 2022-09-30 | -$19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$36.00M derived: sum of 2 quarters · filed 2022-11-04 | -$51.00M 10-Q · filed 2022-11-04 | -$77.00M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2022-06-30 | -$17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$32.00M 10-Q · filed 2022-08-05 | -$58.00M derived: sum of 3 quarters · filed 2023-02-09 | -$69.00M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2022-03-31 | -$15.00M 10-Q · filed 2022-04-28 | -$41.00M derived: sum of 2 quarters · filed 2023-02-09 | -$52.00M derived: sum of 3 quarters · filed 2023-02-09 | -$49.00M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-12-31 | -$26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$37.00M derived: sum of 2 quarters · filed 2023-02-09 | -$34.00M derived: sum of 3 quarters · filed 2023-02-09 | -$50.00M 10-K · filed 2023-02-09 | |
| 2021-09-30 | -$11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$8.00M derived: sum of 2 quarters · filed 2021-11-03 | -$24.00M 10-Q · filed 2021-11-03 | -$9.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$13.00M 10-Q · filed 2021-08-04 | $2.00M derived: sum of 3 quarters · filed 2022-02-16 | -$2.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-03-31 | -$16.00M 10-Q · filed 2021-04-28 | -$1.00M derived: sum of 2 quarters · filed 2022-02-16 | -$5.00M derived: sum of 3 quarters · filed 2022-02-16 | -$10.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $11.00M derived: sum of 2 quarters · filed 2022-02-16 | $6.00M derived: sum of 3 quarters · filed 2022-02-16 | -$14.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$9.00M derived: sum of 2 quarters · filed 2020-10-29 | -$29.00M 10-Q · filed 2020-10-29 | -$31.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2020-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$25.00M 10-Q · filed 2020-07-29 | -$27.00M derived: sum of 3 quarters · filed 2021-02-09 | -$37.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2020-03-31 | -$20.00M 10-Q · filed 2020-05-01 | -$22.00M derived: sum of 2 quarters · filed 2021-02-09 | -$32.00M derived: sum of 3 quarters · filed 2021-02-09 | -$35.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$12.00M derived: sum of 2 quarters · filed 2021-02-09 | -$15.00M derived: sum of 3 quarters · filed 2021-02-09 | -$22.00M 10-K · filed 2021-02-09 | |
| 2019-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$13.00M derived: sum of 2 quarters · filed 2019-10-30 | -$20.00M 10-Q · filed 2019-10-30 | -$5.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2019-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$10.00M 10-Q · filed 2019-07-31 | $5.00M derived: sum of 3 quarters · filed 2020-02-12 | -$35.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2019-03-31 | -$7.00M 10-Q · filed 2019-05-01 | $8.00M derived: sum of 2 quarters · filed 2020-02-12 | -$32.00M derived: sum of 3 quarters · filed 2020-02-12 | -$79.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$25.00M derived: sum of 2 quarters · filed 2020-02-12 | -$72.00M derived: sum of 3 quarters · filed 2020-02-12 | -$68.00M 10-K · filed 2020-02-12 | |
| 2018-09-30 | -$40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$87.00M derived: sum of 2 quarters · filed 2018-10-31 | -$83.00M 10-Q · filed 2018-10-31 | -$98.00M derived: sum of 4 quarters · filed 2018-10-31 | |
| 2018-06-30 | -$47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$43.00M 10-Q · filed 2018-07-27 | -$58.00M derived: sum of 3 quarters · filed 2018-07-27 | -$48.00M derived: sum of 4 quarters · filed 2018-07-27 | |
| 2018-03-31 | $4.00M 10-Q · filed 2018-04-25 | -$11.00M derived: sum of 2 quarters · filed 2018-04-25 | -$1.00M derived: sum of 3 quarters · filed 2018-04-25 | $8.00M derived: sum of 4 quarters · filed 2018-04-25 | |
| 2017-12-31 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$5.00M derived: sum of 2 quarters · filed 2018-02-13 | $4.00M derived: sum of 3 quarters · filed 2018-02-13 | $10.00M 10-K · filed 2018-02-13 | |
| 2017-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $19.00M derived: sum of 2 quarters · filed 2017-10-26 | $25.00M 10-Q · filed 2017-10-26 | $22.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-06-30 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $15.00M 10-Q · filed 2017-07-26 | $12.00M derived: sum of 3 quarters · filed 2019-02-13 | $15.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-03-31 | $6.00M 10-Q · filed 2017-04-27 | $3.00M derived: sum of 2 quarters · filed 2019-02-13 | $6.00M derived: sum of 3 quarters · filed 2019-02-13 | $1.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $0.00 derived: sum of 2 quarters · filed 2019-02-13 | -$5.00M derived: sum of 3 quarters · filed 2019-02-13 | $10.00M 10-K · filed 2019-02-13 | -$38.00M 10-K · filed 2017-02-14 |
| 2016-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$2.00M derived: sum of 2 quarters · filed 2017-10-26 | $13.00M 10-Q · filed 2017-10-26 | $18.00M derived: sum of 4 quarters · filed 2017-10-26 | |
| 2016-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $10.00M 10-Q · filed 2017-07-26 | $15.00M derived: sum of 3 quarters · filed 2017-07-26 | -$34.00M derived: sum of 4 quarters · filed 2017-07-26 | |
| 2016-03-31 | $15.00M 10-Q · filed 2017-04-27 | $20.00M derived: sum of 2 quarters · filed 2017-04-27 | -$29.00M derived: sum of 3 quarters · filed 2017-04-27 | ||
| 2015-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$44.00M derived: sum of 2 quarters · filed 2017-02-14 | -$109.00M 10-K · filed 2017-02-14 | ||
| 2015-09-30 | -$49.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$114.00M 10-Q · filed 2016-10-28 | |||
| 2015-06-30 | -$65.00M 10-Q · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |